Stock 9877 JENSCARE SCIENTIFIC CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:17 17/05/2024 BST 		5-day change 1st Jan Change
4.85 HKD +4.98% Intraday chart for Jenscare Scientific Co., Ltd. +2.11% -78.15%
04-25 Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11% MT
03-27 Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up
Jenscare Scientific Secures HKEX Nod for H Share Circulation
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil
Jenscare Scientific’s CEO, CFO Boost Stake in Firm
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process
Jenscare Scientific Co., Ltd. Announces the Results of the Multicenter Clinical Trial of LuX-Valve Plus at the 2023 TCT in the U.S
Jenscare Scientific Co., Ltd. Receives Confirmation Letter from the National Medical Products Administration of the People's Republic of China Confirms the Acceptance of the Registration Application for Ken-Valve
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Selected for the Expert Panel Scientific Advice Pilot
Jenscare Scientific Co., Ltd. Announces Enrollment in FDA Total Product Life Cycle Advisory Program Pilot
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jenscare Scientific Co., Ltd. Submits Pre-Submission for the Early Feasibility Study of Lux-Valve Plus
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Lifetech Scientific and Jenscare Scientific to Cooperate on Business Development
LifeTech Scientific Corporation Enters Strategic Cooperation Agreement with Jenscare Scientific Co., Ltd
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9877 Stock
  4. News Jenscare Scientific Co., Ltd.
  5. Other languages